Gilead Sciences headquarters in Silicon Valley. Gilead’s HIV drug Sunlenca (lenacapavir) gained FDA approval in 2022. Credit: Sundry Photography via Shutterstock. Public figures, scientists, medical
What You Should Know: – Plenful, an AI workflow automation platform streamlining pharmacy and healthcare operations, today announced a $17M Series A round, increasing its
What You Should Know: – PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to
Listen to the article 4 min This audio is auto-generated. Please let us know if you have feedback. The American Clinical Laboratory Association (ACLA) sued
Listen to the article 2 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Fresenius Medical Care will lay
The TDR Three Key Takeaways regarding Psychedelics and Stutterers: Initial studies suggest psychedelics might help stutterers by altering brain function. Psychedelics have been shown to
Cansortium and RIV Capital Announce Business Combination Combined Company’s footprint will provide access to Florida, New York, Texas, and Pennsylvania, with significant growth potential and
Vancouver, British Columbia–(Newsfile Corp. – May 30, 2024) – In a significant stride towards transforming mental health care, Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF)
Dear BGXX Shareholders, I’m writing to you today to share an update on several developments for Bright Green Corporation (“Bright Green” or the “Company”) over
Vancouver, British Columbia–(Newsfile Corp. – May 30, 2024) – Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) (“Numinus” or the “Company”), a leader in mental health care and in advancing